Your Health, We Care

Home >Drug List>Tivozanib>Indications of Tivozanib

Tivozanib(LuciTivo)

Release date: 2026-01-05 15:40:45     Recommended: 252

Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more previous systemic treatments.